PG.ProteinGroups,PG.Genes,short.name,GO,sub.cell,description,GO.ID,ConditionNorm_P_0_1,ConditionNorm_P_0_2,ConditionNorm_P_0_3,ConditionNorm_P_300_1,ConditionNorm_P_300_2,ConditionNorm_P_300_3,median,Log2,logFC,AveExpr,t,P.Value,adj.P.Val,B,mass,neglog.adj.P.Val.,TotalPeptidesOverallInGene,P0_Undetected,P300_Undetected,medians_.ConditionNorm_P_0_1_ConditionNorm_P_0_2_ConditionNorm_P_0_3,medians_.ConditionNorm_P_300_1_ConditionNorm_P_300_2_ConditionNorm_P_300_3,Ratio,Ratio_log2,ConditionNorm_P_300_1_log2,ConditionNorm_P_300_2_log2,ConditionNorm_P_300_3_log2,tc
A6NJT0,UNCX,UNC4_HUMAN,"nucleus [GO:0005634]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; sequence-specific DNA binding [GO:0043565]; cartilage condensation [GO:0001502]; common myeloid progenitor cell proliferation [GO:0035726]; dorsal spinal cord development [GO:0021516]; olfactory bulb interneuron differentiation [GO:0021889]; pattern specification process [GO:0007389]; regulation of cell differentiation [GO:0045595]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108}.,Homeobox protein unc-4 homolog (Homeobox protein Uncx4.1),GO:0000981; GO:0001502; GO:0005634; GO:0006351; GO:0007389; GO:0021516; GO:0021889; GO:0035726; GO:0043565; GO:0045595,0.005378036,0.000412415,0.000887146,0.385436443,0.394474852,0.376247794,0.385436443,-1.375435109,0.383160497,0.193806115,72.45869559,7.89E-08,7.98E-05,8.055729742,53690,4.098230203,4,0,0,0.000887146,0.385436443,434.4680839,8.76310639,-1.375435109,-1.341994763,-1.410244971,1
Q96PB7,OLFM3,NOE3_HUMAN,AMPA glutamate receptor complex [GO:0032281]; cell junction [GO:0030054]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; synapse [GO:0045202]; eye photoreceptor cell development [GO:0042462],"SUBCELLULAR LOCATION: Secreted {ECO:0000250}. Cell junction, synapse {ECO:0000250}.",Noelin-3 (Olfactomedin-3) (Optimedin),GO:0005615; GO:0005794; GO:0030054; GO:0032281; GO:0042462; GO:0045202,0.069014762,0.073973612,0.075508423,0.284672266,0.293506048,0.275646025,0.284672266,-1.812626148,0.211775847,0.178720189,39.89456036,1.04E-06,0.000372938,4.895292915,54930,3.428363385,4,0,0,0.073973612,0.284672266,3.84829478,1.944219314,-1.812626148,-1.768537861,-1.859111297,1
Q7L775,EPM2AIP1,EPMIP_HUMAN,"cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; nucleoplasm [GO:0005654]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; response to insulin [GO:0032868]",SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000269|PubMed:12782127}.,EPM2A-interacting protein 1 (Laforin-interacting protein),GO:0000981; GO:0003677; GO:0005654; GO:0005737; GO:0005783; GO:0032868; GO:0042802; GO:0045725; GO:2000467,1.00E-07,0.001909822,1.00E-07,0.069658448,0.068857829,0.062974397,0.068857829,-3.860235502,0.066526884,0.033900116,31.39255106,2.91E-06,0.000753806,3.626390536,70370,3.122740267,9,2,0,1.00E-07,0.068857829,688578.2864,19.39326116,-3.843557855,-3.860235502,-3.98909078,1
Q92785,DPF2,REQU_HUMAN,"centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear chromatin [GO:0000790]; nucleoplasm [GO:0005654]; metal ion binding [GO:0046872]; RNA polymerase II proximal promoter sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=30% nuclear. 70% cytoplasmic.,"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)",GO:0000790; GO:0000978; GO:0000981; GO:0005654; GO:0005813; GO:0005829; GO:0006351; GO:0006915; GO:0043231; GO:0046872; GO:0097190,0.000285473,0.00031122,0.000257807,0.128806406,0.148613496,0.136788177,0.136788177,-2.86998456,0.137784526,0.069177096,24.88260241,7.89E-06,0.00146855,2.398005459,44155,2.833111397,10,0,0,0.000285473,0.136788177,479.1637044,8.904374821,-2.956723749,-2.750362959,-2.86998456,1
A1L0T0,ILVBL,ILVBL_HUMAN,integral component of membrane [GO:0016021]; membrane [GO:0016020]; magnesium ion binding [GO:0000287]; thiamine pyrophosphate binding [GO:0030976]; transferase activity [GO:0016740],SUBCELLULAR LOCATION: Membrane; Single-pass membrane protein.,Acetolactate synthase-like protein (EC 2.2.1.-) (IlvB-like protein),GO:0000287; GO:0016020; GO:0016021; GO:0016740; GO:0030976,0.000134635,0.000853109,7.70E-05,0.053742441,0.046528602,0.053184778,0.053184778,-4.232842801,0.050797037,0.025753421,22.64061139,1.18E-05,0.001777227,1.899858458,67868,2.750257219,8,0,0,0.000134635,0.053184778,395.0298901,8.625818009,-4.217794344,-4.425738365,-4.232842801,1
P23743,DGKA,DGKA_HUMAN,cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; diacylglycerol kinase activity [GO:0004143]; kinase activity [GO:0016301]; NAD+ kinase activity [GO:0003951]; phospholipid binding [GO:0005543]; diacylglycerol metabolic process [GO:0046339]; glycerolipid metabolic process [GO:0046486]; intracellular signal transduction [GO:0035556]; lipid phosphorylation [GO:0046834]; phosphatidic acid biosynthetic process [GO:0006654]; platelet activation [GO:0030168]; protein kinase C-activating G-protein coupled receptor signaling pathway [GO:0007205],,Diacylglycerol kinase alpha (DAG kinase alpha) (EC 2.7.1.107) (80 kDa diacylglycerol kinase) (Diglyceride kinase alpha) (DGK-alpha),GO:0003951; GO:0004143; GO:0005509; GO:0005524; GO:0005543; GO:0005829; GO:0005886; GO:0006654; GO:0007205; GO:0016020; GO:0016301; GO:0030168; GO:0035556; GO:0046339; GO:0046486; GO:0046834,0.000216141,5.57E-05,5.74E-05,0.104046195,0.118508379,0.10212393,0.104046195,-3.264703891,0.108116422,0.054167957,21.7233952,1.41E-05,0.001950861,1.681906117,82630,2.709773636,9,0,0,5.74E-05,0.104046195,1812.786915,10.82399364,-3.264703891,-3.076939023,-3.291607131,1
Q96EY1,DNAJA3,DNJA3_HUMAN,cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of plasma membrane [GO:0019897]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; postsynaptic membrane [GO:0045211]; ATP binding [GO:0005524]; GTPase regulator activity [GO:0030695]; Hsp70 protein binding [GO:0030544]; interferon-gamma receptor binding [GO:0005133]; metal ion binding [GO:0046872]; NF-kappaB binding [GO:0051059]; protein kinase binding [GO:0019901]; transcription factor binding [GO:0008134]; unfolded protein binding [GO:0051082]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation-induced cell death of T cells [GO:0006924]; cell aging [GO:0007569]; mitochondrial DNA replication [GO:0006264]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of interferon-gamma-mediated signaling pathway [GO:0060336]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of programmed cell death [GO:0043069]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuromuscular junction development [GO:0007528]; positive regulation of apoptotic process [GO:0043065]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell proliferation [GO:0042102]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; response to interferon-gamma [GO:0034341]; skeletal muscle acetylcholine-gated channel clustering [GO:0071340]; small GTPase mediated signal transduction [GO:0007264]; T cell differentiation in thymus [GO:0033077],"SUBCELLULAR LOCATION: Mitochondrion matrix. Cytoplasm, cytosol {ECO:0000250}. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250}; Peripheral membrane protein {ECO:0000250}. Note=Recruited to the postsynaptic cell membrane of the neuromuscular junction through interaction with MUSK. {ECO:0000250}.","DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog)",GO:0000122; GO:0005133; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005759; GO:0005829; GO:0006264; GO:0006457; GO:0006469; GO:0006919; GO:0006924; GO:0007005; GO:0007264; GO:0007528; GO:0007569; GO:0008134; GO:0008285; GO:0009408; GO:0019897; GO:0019901; GO:0030054; GO:0030544; GO:0030695; GO:0031398; GO:0031594; GO:0032088; GO:0033077; GO:0034341; GO:0042102; GO:0042645; GO:0043065; GO:0043066; GO:0043069; GO:0043124; GO:0043154; GO:0043231; GO:0045211; GO:0046872; GO:0050821; GO:0051059; GO:0051082; GO:0060336; GO:0071340,0.00621556,0.000206715,0.000255026,0.053771814,0.053879213,0.04965578,0.053771814,-4.21700605,0.050209835,0.027330685,21.45067299,1.49E-05,0.001965301,1.615353759,52489,2.706570851,11,0,0,0.000255026,0.053771814,210.8481334,7.72006044,-4.21700605,-4.21412742,-4.331894523,1
O75093,SLIT1,SLIT1_HUMAN,extracellular space [GO:0005615]; intracellular [GO:0005622]; calcium ion binding [GO:0005509]; Roundabout binding [GO:0048495]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028],SUBCELLULAR LOCATION: Secreted {ECO:0000250}.,Slit homolog 1 protein (Slit-1) (Multiple epidermal growth factor-like domains protein 4) (Multiple EGF-like domains protein 4),GO:0005509; GO:0005615; GO:0005622; GO:0007097; GO:0007411; GO:0008045; GO:0022028; GO:0031290; GO:0033563; GO:0048495; GO:0048846; GO:0048853; GO:0050919; GO:0051964,1.00E-07,1.00E-07,1.00E-07,0.13721897,0.12505071,0.149524033,0.13721897,-2.865448156,0.137264471,0.068632335,20.18812356,1.93E-05,0.002249439,1.296015753,167926,2.647925761,13,3,0,1.00E-07,0.13721897,1372189.697,20.38804851,-2.865448156,-2.99941485,-2.741550704,1
O94812,BAIAP3,BAIP3_HUMAN,"cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; late endosome membrane [GO:0031902]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588]; calcium ion binding [GO:0005509]; phospholipid binding [GO:0005543]; SNARE binding [GO:0000149]; syntaxin binding [GO:0019905]; dense core granule maturation [GO:1990502]; exocytosis [GO:0006887]; G-protein coupled receptor signaling pathway [GO:0007186]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of neurotransmitter secretion [GO:0001956]; regulation of dense core granule exocytosis [GO:1905413]; regulation of synaptic transmission, GABAergic [GO:0032228]; retrograde transport, endosome to Golgi [GO:0042147]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:28626000}. Recycling endosome membrane {ECO:0000269|PubMed:28626000}; Peripheral membrane protein {ECO:0000305|PubMed:28626000}. Late endosome membrane {ECO:0000269|PubMed:28626000}; Peripheral membrane protein {ECO:0000305|PubMed:28626000}. Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:28626000}; Peripheral membrane protein {ECO:0000305|PubMed:28626000}. Cell membrane {ECO:0000269|PubMed:28626000}; Peripheral membrane protein {ECO:0000305|PubMed:28626000}. Note=Rapidly recruited to the plasma membrane and to Golgi structures in response to increased intracellular calcium concentration. {ECO:0000269|PubMed:28626000}.",BAI1-associated protein 3 (BAP3) (Brain-specific angiogenesis inhibitor I-associated protein 3),GO:0000149; GO:0001956; GO:0005509; GO:0005543; GO:0005783; GO:0005829; GO:0005886; GO:0006887; GO:0007186; GO:0019905; GO:0031902; GO:0032228; GO:0032588; GO:0035774; GO:0042147; GO:0055038; GO:0098793; GO:1905413; GO:1990502,1.00E-07,1.00E-07,1.00E-07,0.297708247,0.272750945,0.246417911,0.272750945,-1.874343899,0.272292268,0.136146234,19.10694006,2.45E-05,0.002555236,1.00659393,131901,2.592568962,4,3,0,1.00E-07,0.272750945,2727509.451,21.37915277,-1.74802891,-1.874343899,-2.020820973,1
Q9ULN7,PNMA8B,PNM8B_HUMAN,,,Paraneoplastic antigen-like protein 8B (PNMA-like protein 2),,9.32E-05,0.00010287,9.88E-05,0.148897281,0.176361015,0.179684614,0.176361015,-2.50339641,0.16821599,0.084206308,17.91649269,3.22E-05,0.002903462,0.668801525,68615,2.537083906,5,0,0,9.88E-05,0.176361015,1784.140395,10.80101343,-2.747610689,-2.50339641,-2.476461213,1
P49918,CDKN1C,CDN1C_HUMAN,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; protein kinase inhibitor activity [GO:0004860]; protein-containing complex binding [GO:0044877]; cell cycle arrest [GO:0007050]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of kinase activity [GO:0033673]; negative regulation of phosphorylation [GO:0042326]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of mitotic cell cycle [GO:0007346]",SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.,Cyclin-dependent kinase inhibitor 1C (Cyclin-dependent kinase inhibitor p57) (p57Kip2),GO:0004860; GO:0004861; GO:0005634; GO:0005737; GO:0007050; GO:0007346; GO:0030511; GO:0033673; GO:0042326; GO:0044877; GO:0045892; GO:0045893; GO:0050680; GO:1904030,3.84E-05,0.003720397,6.05E-05,0.23566016,0.202999477,0.195818018,0.202999477,-2.300452087,0.210219464,0.10638282,17.72838679,3.37E-05,0.002997949,0.613432271,32177,2.523175811,3,0,0,6.05E-05,0.202999477,3357.99919,11.71338617,-2.085220212,-2.300452087,-2.352414575,1
Q9Y4P1,ATG4B,ATG4B_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; cysteine-type endopeptidase activity [GO:0004197]; cysteine-type peptidase activity [GO:0008234]; endopeptidase activity [GO:0004175]; autophagosome assembly [GO:0000045]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; autophagy of nucleus [GO:0044804]; C-terminal protein lipidation [GO:0006501]; macroautophagy [GO:0016236]; positive regulation of protein catabolic process [GO:0045732]; protein delipidation [GO:0051697]; protein targeting to membrane [GO:0006612]; proteolysis [GO:0006508],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.,Cysteine protease ATG4B (EC 3.4.22.-) (AUT-like 1 cysteine endopeptidase) (Autophagin-1) (Autophagy-related cysteine endopeptidase 1) (Autophagy-related protein 4 homolog B) (hAPG4B),GO:0000045; GO:0000422; GO:0004175; GO:0004197; GO:0005737; GO:0005829; GO:0006501; GO:0006508; GO:0006612; GO:0006914; GO:0008234; GO:0016236; GO:0044804; GO:0045732; GO:0051697,1.00E-07,1.00E-07,1.00E-07,0.006209754,0.00561793,0.004867365,0.00561793,-7.475745744,0.005564916,0.002782558,14.73675211,7.41E-05,0.004731511,-0.353312427,44294,2.325000159,14,3,0,1.00E-07,0.00561793,56179.2958,15.77775092,-7.331248253,-7.475745744,-7.682643439,1
Q8NFT8,DNER,DNER_HUMAN,dendrite [GO:0030425]; early endosome [GO:0005769]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; clathrin binding [GO:0030276]; Notch binding [GO:0005112]; transmembrane signaling receptor activity [GO:0004888]; central nervous system development [GO:0007417]; endocytosis [GO:0006897]; glial cell differentiation [GO:0010001]; neuron migration [GO:0001764]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; skeletal muscle fiber development [GO:0048741]; synapse assembly [GO:0007416],SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane protein. Note=Present on the membrane of dendrites and cell bodies but excluded from axonal membrane. Also found in early endosomes in the somatodendritic region (By similarity). {ECO:0000250}.,Delta and Notch-like epidermal growth factor-related receptor,GO:0001764; GO:0004888; GO:0005112; GO:0005509; GO:0005769; GO:0005886; GO:0006897; GO:0007219; GO:0007220; GO:0007416; GO:0007417; GO:0010001; GO:0016021; GO:0030276; GO:0030425; GO:0043025; GO:0048741,0.002997794,0.010310637,0.005962134,0.308840716,0.28263796,0.236385186,0.28263796,-1.822972856,0.269531099,0.141189071,13.15641155,0.000119808,0.006212283,-0.943382839,78475,2.206748771,8,0,0,0.005962134,0.28263796,47.40550617,5.566982733,-1.69506513,-1.822972856,-2.080788471,1
O00571,DDX3X,DDX3X_HUMAN,"cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrial outer membrane [GO:0005741]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; ATP binding [GO:0005524]; ATP-dependent DNA helicase activity [GO:0004003]; ATP-dependent RNA helicase activity [GO:0004004]; ATPase activity [GO:0016887]; cadherin binding [GO:0045296]; CTPase activity [GO:0043273]; DNA binding [GO:0003677]; eukaryotic initiation factor 4E binding [GO:0008190]; GTPase activity [GO:0003924]; mRNA 5'-UTR binding [GO:0048027]; nucleoside-triphosphatase activity [GO:0017111]; poly(A) binding [GO:0008143]; protein serine/threonine kinase activator activity [GO:0043539]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; RNA strand annealing activity [GO:0033592]; transcription factor binding [GO:0008134]; translation initiation factor binding [GO:0031369]; cellular response to arsenic-containing substance [GO:0071243]; cellular response to osmotic stress [GO:0071470]; chromosome segregation [GO:0007059]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; mature ribosome assembly [GO:0042256]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein complex assembly [GO:0031333]; negative regulation of translation [GO:0017148]; neutrophil degranulation [GO:0043312]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of translational initiation [GO:0045948]; positive regulation of viral genome replication [GO:0045070]; protein localization to cytoplasmic stress granule [GO:1903608]; response to virus [GO:0009615]; RNA secondary structure unwinding [GO:0010501]; stress granule assembly [GO:0034063]; transcription, DNA-templated [GO:0006351]; translational initiation [GO:0006413]; viral process [GO:0016032]; Wnt signaling pathway [GO:0016055]","SUBCELLULAR LOCATION: Nucleus speckle. Cytoplasm. Mitochondrion outer membrane. Note=Located predominantly in nuclear speckles and, at low levels, throughout the cytoplasm. Located to the outer side of nuclear pore complexes (NPC). Shuttles between the nucleus and the cytoplasm in a XPO1 and may be also in a NFX1-dependent manner. Associated with polyadenylated mRNAs in the cytoplasm and the nucleus. Predominantly located in nucleus during G(0) phase and in the cytoplasm during G1/S phase.","ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2)",GO:0003677; GO:0003723; GO:0003924; GO:0004003; GO:0004004; GO:0005524; GO:0005576; GO:0005634; GO:0005730; GO:0005737; GO:0005741; GO:0005829; GO:0006351; GO:0006413; GO:0007059; GO:0008134; GO:0008143; GO:0008190; GO:0008625; GO:0009615; GO:0010494; GO:0010501; GO:0010628; GO:0016032; GO:0016055; GO:0016607; GO:0016887; GO:0017111; GO:0017148; GO:0030307; GO:0030308; GO:0031333; GO:0031369; GO:0032728; GO:0033592; GO:0034063; GO:0034774; GO:0035556; GO:0035613; GO:0042256; GO:0043024; GO:0043065; GO:0043066; GO:0043154; GO:0043273; GO:0043280; GO:0043312; GO:0043539; GO:0045070; GO:0045087; GO:0045296; GO:0045727; GO:0045944; GO:0045948; GO:0048027; GO:0070062; GO:0071243; GO:0071470; GO:0071651; GO:0071902; GO:0090263; GO:0097193; GO:1900087; GO:1903608; GO:1904813; GO:2001243,1.00E-07,9.27E-05,1.00E-07,0.141546167,0.115322665,0.109064726,0.115322665,-3.116252013,0.121946887,0.061004409,12.73547113,0.000137463,0.006762548,-1.111969932,73243,2.169889659,6,2,0,1.00E-07,0.115322665,1153226.65,20.13724465,-2.820655416,-3.116252013,-3.196743514,1
Q9NV31,IMP3,IMP3_HUMAN,Mpp10 complex [GO:0034457]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; preribosome [GO:0030684]; small-subunit processome [GO:0032040]; RNA binding [GO:0003723]; snoRNA binding [GO:0030515]; rRNA processing [GO:0006364],"SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12655004}.",U3 small nucleolar ribonucleoprotein protein IMP3 (U3 snoRNP protein IMP3) (BRMS2),GO:0003723; GO:0005634; GO:0005654; GO:0005730; GO:0006364; GO:0030515; GO:0030684; GO:0032040; GO:0034457,1.00E-07,1.00E-07,1.13E-05,0.113717045,0.150482088,0.127161891,0.127161891,-2.975261722,0.130449856,0.065228747,12.62085012,0.000142814,0.006897984,-1.158792099,21850,2.16127783,6,2,0,1.00E-07,0.127161891,1271618.907,20.27823494,-3.136479581,-2.732336321,-2.975261722,1
Q9Y3C6,PPIL1,PPIL1_HUMAN,"catalytic step 2 spliceosome [GO:0071013]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U2-type catalytic step 2 spliceosome [GO:0071007]; cyclosporin A binding [GO:0016018]; disordered domain specific binding [GO:0097718]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; mRNA splicing, via spliceosome [GO:0000398]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770}.",Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1),GO:0000398; GO:0000413; GO:0003755; GO:0005634; GO:0005654; GO:0006457; GO:0016018; GO:0071007; GO:0071013; GO:0097718,2.26E-05,1.95E-05,3.32E-05,0.008083901,0.009638276,0.010770311,0.009638276,-6.697009148,0.009472388,0.004761302,12.60778963,0.000143439,0.006897984,-1.164152803,18237,2.16127783,7,0,0,2.26E-05,0.009638276,425.6565617,8.73354606,-6.95073257,-6.697009148,-6.536796276,1
Q719H9,KCTD1,KCTD1_HUMAN,"nucleoplasm [GO:0005654]; nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; protein homooligomerization [GO:0051260]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18358072}.,BTB/POZ domain-containing protein KCTD1 (Potassium channel tetramerization domain-containing protein 1),GO:0000122; GO:0003714; GO:0005634; GO:0005654; GO:0006351; GO:0008134; GO:0042802; GO:0045892; GO:0051260,0.055090573,0.08142537,0.050740332,0.211043005,0.231269925,0.246565168,0.231269925,-2.112350429,0.167207274,0.146022395,12.35620571,0.000156177,0.007305307,-1.268455272,29405,2.136361558,3,0,0,0.055090573,0.231269925,4.197994536,2.069700289,-2.244391083,-2.112350429,-2.019959092,1
Q9NWQ8,PAG1,PHAG1_HUMAN,integral component of plasma membrane [GO:0005887]; intracellular [GO:0005622]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; SH2 domain binding [GO:0042169]; SH3/SH2 adaptor activity [GO:0005070]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]; adaptive immune response [GO:0002250]; intracellular signal transduction [GO:0035556]; negative regulation of T cell activation [GO:0050868]; regulation of T cell activation [GO:0050863]; signal transduction [GO:0007165]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10790433, ECO:0000269|PubMed:18070987}; Single-pass type III membrane protein {ECO:0000269|PubMed:10790433, ECO:0000269|PubMed:18070987}. Note=Present in lipid rafts.",Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp),GO:0002250; GO:0005068; GO:0005070; GO:0005622; GO:0005886; GO:0005887; GO:0007165; GO:0007169; GO:0035556; GO:0042169; GO:0045121; GO:0050852; GO:0050863; GO:0050868,1.00E-07,1.00E-07,0.016220471,0.128847372,0.102056002,0.118949701,0.118949701,-3.071576451,0.111210801,0.061012291,12.15325495,0.000167474,0.007334144,-1.354068806,46981,2.134650551,6,2,0,1.00E-07,0.118949701,1189497.008,20.18192021,-2.956264985,-3.292567061,-3.071576451,1
Q9HCH0,NCKAP5L,NCK5L_HUMAN,centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule plus-end [GO:0035371]; microtubule bundle formation [GO:0001578]; microtubule depolymerization [GO:0007019],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:26482847, ECO:0000269|PubMed:26485573, ECO:0000269|PubMed:26549230}. Note=Localizes to microtubule plus ends (PubMed:26485573, PubMed:26482847). Associates with centrosomes during interphase, but dissociates from these structures from the onset of mitosis (PubMed:26549230). {ECO:0000269|PubMed:26482847, ECO:0000269|PubMed:26485573, ECO:0000269|PubMed:26549230}.",Nck-associated protein 5-like (NCKAP5-like) (Centrosomal protein of 169 kDa) (Cep169),GO:0001578; GO:0005737; GO:0005813; GO:0007019; GO:0035371,0.000147645,0.003837467,5.98E-05,0.122527061,0.115732668,0.151605986,0.122527061,-3.028827686,0.12860693,0.065651773,12.06967372,0.000172417,0.007376895,-1.389719917,139013,2.132126426,4,0,0,0.000147645,0.122527061,829.8739493,9.69674841,-3.028827686,-3.111131943,-2.721601374,1
P14373,TRIM27,TRI27_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; fibrillar center [GO:0001650]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; Arp2/3 complex-mediated actin nucleation [GO:0034314]; cell proliferation [GO:0008283]; innate immune response [GO:0045087]; interferon-gamma secretion [GO:0072643]; negative regulation of adaptive immune response [GO:0002820]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of interleukin-2 secretion [GO:1900041]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of viral release from host cell [GO:1902187]; negative regulation of viral transcription [GO:0032897]; positive regulation of actin nucleation [GO:0051127]; positive regulation of DNA binding transcription factor activity [GO:0051091]; protein K63-linked ubiquitination [GO:0070534]; protein trimerization [GO:0070206]; retrograde transport, endosome to Golgi [GO:0042147]; spermatogenesis [GO:0007283]; transcription, DNA-templated [GO:0006351]","SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17156811}. Cytoplasm {ECO:0000269|PubMed:17156811}. Nucleus, PML body {ECO:0000250}. Early endosome {ECO:0000269|PubMed:1437549, ECO:0000269|PubMed:23452853, ECO:0000269|PubMed:9247190}. Note=Nuclear or cytoplasmic depending on the cell type (By similarity). Colocalized with PML and EIF3S6 in nuclear bodies. Recruited to retromer-containing endosomes via interaction with MAGEL2 (PubMed:23452853). {ECO:0000250, ECO:0000269|PubMed:23452853}.",Zinc finger protein RFP (EC 2.3.2.27) (RING finger protein 76) (RING-type E3 ubiquitin transferase TRIM27) (Ret finger protein) (Tripartite motif-containing protein 27),GO:0000122; GO:0001650; GO:0002820; GO:0003676; GO:0003677; GO:0004714; GO:0004842; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005768; GO:0005769; GO:0005829; GO:0005887; GO:0006351; GO:0006469; GO:0007283; GO:0008270; GO:0008283; GO:0016020; GO:0016605; GO:0031965; GO:0032720; GO:0032897; GO:0034314; GO:0042147; GO:0042802; GO:0045087; GO:0045814; GO:0046872; GO:0051091; GO:0051127; GO:0061630; GO:0070206; GO:0070534; GO:0072643; GO:0090281; GO:1900041; GO:1902187,0.000642864,0.003053985,0.001000392,0.216076523,0.235201996,0.174702571,0.216076523,-2.210385762,0.207094616,0.105113055,12.04212775,0.000174085,0.007376895,-1.40152051,58490,2.132126426,6,0,0,0.001000392,0.216076523,215.9919086,7.754833458,-2.210385762,-2.08802779,-2.517027259,1
Q6IEE7,TMEM132E,T132E_HUMAN,integral component of membrane [GO:0016021],SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.,Transmembrane protein 132E,GO:0016021,0.005191566,0.002573591,0.005957239,0.182553909,0.176471811,0.131444681,0.176471811,-2.502490343,0.158916002,0.084032133,10.22391766,0.000345914,0.011159507,-2.242401994,107094,1.952354998,6,0,0,0.005191566,0.176471811,33.99201988,5.087124188,-2.45360553,-2.502490343,-2.927472336,1
Q96CX2,KCTD12,KCD12_HUMAN,cell junction [GO:0030054]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; protein homooligomerization [GO:0051260],"SUBCELLULAR LOCATION: Cell junction, synapse, presynaptic cell membrane. Cell junction, synapse, postsynaptic cell membrane {ECO:0000250}.",BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain),GO:0003723; GO:0030054; GO:0042734; GO:0042802; GO:0045211; GO:0051260,1.00E-07,1.00E-07,3.72E-05,0.166433012,0.172926056,0.122712067,0.166433012,-2.586986478,0.154011254,0.077018084,10.14937161,0.000356641,0.011182601,-2.279766901,35701,1.951457184,11,2,0,1.00E-07,0.166433012,1664330.116,20.66651019,-2.586986478,-2.531772828,-3.026650975,1
O94829,IPO13,IPO13_HUMAN,cytoplasm [GO:0005737]; nuclear membrane [GO:0031965]; nuclear localization sequence binding [GO:0008139]; protein transporter activity [GO:0008565]; Ran GTPase binding [GO:0008536]; protein import into nucleus [GO:0006606],SUBCELLULAR LOCATION: Cytoplasm. Nucleus.,Importin-13 (Imp13) (Karyopherin-13) (Kap13) (Ran-binding protein 13) (RanBP13),GO:0005737; GO:0006606; GO:0008139; GO:0008536; GO:0008565; GO:0031965,0.025686719,0.020016438,0.026269082,0.084603982,0.077829686,0.067166236,0.077829686,-3.683535658,0.052542555,0.050262024,10.01146107,0.000377582,0.011400774,-2.349562269,108195,1.94306566,10,0,0,0.025686719,0.077829686,3.029958214,1.599297898,-3.563130615,-3.683535658,-3.896120018,1
Q9NRN7,AASDHPPT,ADPPT_HUMAN,cytosol [GO:0005829]; extracellular exosome [GO:0070062]; holo-[acyl-carrier-protein] synthase activity [GO:0008897]; magnesium ion binding [GO:0000287]; lysine biosynthetic process via aminoadipic acid [GO:0019878]; pantothenate metabolic process [GO:0015939],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12815048}.,L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (EC 2.7.8.-) (4'-phosphopantetheinyl transferase) (Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase) (AASD-PPT) (LYS5 ortholog),GO:0000287; GO:0005829; GO:0008897; GO:0015939; GO:0019878; GO:0070062,7.52E-05,1.00E-07,1.00E-07,0.145656961,0.13564026,0.101655057,0.13564026,-2.882142638,0.127625634,0.063837943,9.959289263,0.000385894,0.011400774,-2.376196287,35776,1.94306566,12,2,0,1.00E-07,0.13564026,1356402.602,20.37135403,-2.779353446,-2.882142638,-3.298246109,1
Q9H5H4,ZNF768,ZN768_HUMAN,"DNA-directed RNA polymerase II, core complex [GO:0005665]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription by RNA polymerase II [GO:0006366]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.,Zinc finger protein 768,GO:0000981; GO:0003677; GO:0003723; GO:0005665; GO:0006366; GO:0046872,1.00E-07,1.00E-07,1.00E-07,0.078302617,0.05958895,0.056699812,0.05958895,-4.068811358,0.064863693,0.032431947,9.953864993,0.000386771,0.011400774,-2.378972747,60229,1.94306566,6,3,0,1.00E-07,0.05958895,595889.5022,19.18468531,-3.674795673,-4.068811358,-4.140512227,1
Q5TGY3,AHDC1,AHDC1_HUMAN,DNA binding [GO:0003677],,AT-hook DNA-binding motif-containing protein 1,GO:0003677,5.37E-05,2.46E-05,0.001216227,0.092459135,0.107418937,0.072564144,0.092459135,-3.435040323,0.090382538,0.045622803,9.295820322,0.000513943,0.013273075,-2.726499189,168349,1.877028457,15,0,0,5.37E-05,0.092459135,1720.601599,10.74869737,-3.435040323,-3.218679751,-3.784599346,1
Q9NYQ7,CELSR3,CELR3_HUMAN,"integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; calcium ion binding [GO:0005509]; G-protein coupled receptor activity [GO:0004930]; axonal fasciculation [GO:0007413]; cilium assembly [GO:0060271]; dopaminergic neuron axon guidance [GO:0036514]; G-protein coupled receptor signaling pathway [GO:0007186]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neuron migration [GO:0001764]; planar cell polarity pathway involved in axon guidance [GO:1904938]; regulation of protein localization [GO:0032880]; regulation of protein phosphorylation [GO:0001932]; serotonergic neuron axon guidance [GO:0036515]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.,Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2),GO:0001764; GO:0001932; GO:0004930; GO:0005509; GO:0005886; GO:0007156; GO:0007186; GO:0007413; GO:0016021; GO:0032880; GO:0036514; GO:0036515; GO:0060071; GO:0060271; GO:1904938,0.000299172,0.000327281,0.000245871,0.071431546,0.072782532,0.050343901,0.071431546,-3.807294842,0.064561885,0.032571717,9.234003806,0.000528353,0.01342048,-2.76028472,358185,1.872231961,31,0,0,0.000299172,0.071431546,238.7638103,7.899440372,-3.807294842,-3.780263949,-4.312039181,1
Q9NYY8,FASTKD2,FAKD2_HUMAN,intercellular bridge [GO:0045171]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; ribonucleoprotein granule [GO:0035770]; protein kinase activity [GO:0004672]; RNA binding [GO:0003723]; rRNA binding [GO:0019843]; cellular respiration [GO:0045333]; mitochondrial large ribosomal subunit assembly [GO:1902775],"SUBCELLULAR LOCATION: Mitochondrion matrix, mitochondrion nucleoid {ECO:0000269|PubMed:20869947, ECO:0000269|PubMed:25683715}. Note=Localizes to mitochondrial RNA granules found in close proximity to the mitochondrial nucleoids. {ECO:0000269|PubMed:25683715}.","FAST kinase domain-containing protein 2, mitochondrial",GO:0003723; GO:0004672; GO:0005634; GO:0005739; GO:0019843; GO:0035770; GO:0042645; GO:0045171; GO:0045333; GO:1902775,0.000108815,0.000222193,0.000140905,0.070011519,0.080468827,0.103218023,0.080468827,-3.635426191,0.084408819,0.042361714,8.947535681,0.000601947,0.014337582,-2.919566692,81463,1.843524088,8,0,0,0.000140905,0.080468827,571.0873701,9.157567669,-3.836263877,-3.635426191,-3.276233193,1
P50542,PEX5,PEX5_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; intracellular [GO:0005622]; membrane [GO:0016020]; peroxisomal matrix [GO:0005782]; peroxisomal membrane [GO:0005778]; peroxisome [GO:0005777]; protein-containing complex [GO:0032991]; enzyme binding [GO:0019899]; peroxisome matrix targeting signal-1 binding [GO:0005052]; peroxisome targeting sequence binding [GO:0000268]; protein C-terminus binding [GO:0008022]; protein N-terminus binding [GO:0047485]; small GTPase binding [GO:0031267]; negative regulation of protein homotetramerization [GO:1901094]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, translocation [GO:0016561]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; protein ubiquitination [GO:0016567]",SUBCELLULAR LOCATION: Cytoplasm. Peroxisome membrane; Peripheral membrane protein. Note=Its distribution appears to be dynamic. It is probably a cycling receptor found mainly in the cytoplasm and as well associated to the peroxisomal membrane through a docking factor (PEX13).,Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1),GO:0000268; GO:0005052; GO:0005622; GO:0005737; GO:0005777; GO:0005778; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0008022; GO:0016020; GO:0016558; GO:0016560; GO:0016561; GO:0016567; GO:0019899; GO:0031267; GO:0032991; GO:0045046; GO:0047485; GO:0051262; GO:1901094,0.002247134,0.000135719,0.000215602,0.081426834,0.086792028,0.057272916,0.081426834,-3.618351885,0.074297774,0.038015039,8.479127685,0.000751329,0.016240841,-3.190136313,70865,1.789391478,19,0,0,0.000215602,0.081426834,377.6721461,8.560990577,-3.618351885,-3.526293656,-4.126003127,1
Q9H1D9,POLR3F,RPC6_HUMAN,cytosol [GO:0005829]; DNA-directed RNA polymerase III complex [GO:0005666]; nucleoplasm [GO:0005654]; DNA-directed 5'-3' RNA polymerase activity [GO:0003899]; double-stranded DNA binding [GO:0003690]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; regulation of transcription by RNA polymerase III [GO:0006359]; transcription by RNA polymerase III [GO:0006383],SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.,DNA-directed RNA polymerase III subunit RPC6 (RNA polymerase III subunit C6) (DNA-directed RNA polymerase III subunit F) (RNA polymerase III 39 kDa subunit) (RPC39),GO:0003690; GO:0003899; GO:0005654; GO:0005666; GO:0005829; GO:0006359; GO:0006383; GO:0032728; GO:0045087; GO:0045089; GO:0051607,0.001525292,6.95E-06,2.65E-05,0.070296241,0.047620195,0.0761297,0.070296241,-3.830408649,0.064162466,0.032600812,7.654315058,0.001141988,0.021022407,-3.700418174,35684,1.677317569,4,0,0,2.65E-05,0.070296241,2653.399462,11.37362617,-3.830408649,-4.392282659,-3.715396802,1
Q68D91,MBLAC2,MBLC2_HUMAN,extracellular exosome [GO:0070062]; hydrolase activity [GO:0016787]; metal ion binding [GO:0046872],,Metallo-beta-lactamase domain-containing protein 2 (EC 3.-.-.-),GO:0016787; GO:0046872; GO:0070062,1.00E-07,1.00E-07,1.00E-07,0.058815931,0.05980444,0.037764522,0.058815931,-4.0876492,0.052128198,0.026064199,7.535887664,0.001216716,0.021960323,-3.777573383,31372,1.658361276,7,3,0,1.00E-07,0.058815931,588159.3144,19.16584746,-4.0876492,-4.063603586,-4.72682465,1
Q969R2,OSBP2,OSBP2_HUMAN,apical dendrite [GO:0097440]; membrane [GO:0016020]; cholesterol binding [GO:0015485]; lipid transport [GO:0006869]; spermatid development [GO:0007286],SUBCELLULAR LOCATION: Membrane; Peripheral membrane protein.,Oxysterol-binding protein 2 (Oxysterol-binding protein-related protein 4) (ORP-4) (OSBP-related protein 4),GO:0006869; GO:0007286; GO:0015485; GO:0016020; GO:0097440,1.00E-07,1.00E-07,1.00E-07,0.016462768,0.020637143,0.012677692,0.016462768,-5.924649272,0.016592434,0.008296317,7.498477978,0.001241549,0.022070122,-3.802162383,101266,1.656195265,4,3,0,1.00E-07,0.016462768,164627.679,17.32884739,-5.924649272,-5.598612934,-6.301564029,1
Q96PE2,ARHGEF17,ARHGH_HUMAN,cytosol [GO:0005829]; guanyl-nucleotide exchange factor activity [GO:0005085]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; actin cytoskeleton organization [GO:0030036]; G-protein coupled receptor signaling pathway [GO:0007186]; positive regulation of apoptotic process [GO:0043065]; regulation of Rho protein signal transduction [GO:0035023]; regulation of small GTPase mediated signal transduction [GO:0051056],,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),GO:0005085; GO:0005089; GO:0005829; GO:0007186; GO:0030036; GO:0035023; GO:0043065; GO:0051056,0.034475167,0.00020205,0.000124214,0.166777547,0.122503664,0.176263857,0.166777547,-2.584003021,0.143581212,0.083391083,7.410994196,0.001302075,0.02250891,-3.860077477,221673,1.647645537,10,0,0,0.00020205,0.166777547,825.4290543,9.68900041,-2.584003021,-3.02910319,-2.504191419,1
Q8IYT2,CMTR2,CMTR2_HUMAN,cytoplasm [GO:0005737]; nucleus [GO:0005634]; mRNA (nucleoside-2'-O-)-methyltransferase activity [GO:0004483]; 7-methylguanosine mRNA capping [GO:0006370]; cap2 mRNA methylation [GO:0097310],SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:21310715}. Cytoplasm {ECO:0000269|PubMed:21310715}.,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (EC 2.1.1.296) (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2) (HMTr2) (MTr2) (FtsJ methyltransferase domain-containing protein 1) (Protein adrift homolog),GO:0004483; GO:0005634; GO:0005737; GO:0006370; GO:0097310,9.58E-05,0.160727071,0.000115788,0.570537511,0.474767045,0.644965665,0.570537511,-0.809606353,0.509777193,0.308534811,7.280768873,0.001398967,0.023277717,-3.947378379,88120,1.633059621,3,0,0,0.000115788,0.570537511,4927.412207,12.26661445,-0.809606353,-1.074708298,-0.632705734,1
Q7L523,RRAGA,RRAGA_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; EGO complex [GO:0034448]; Gtr1-Gtr2 GTPase complex [GO:1990131]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; nucleus [GO:0005634]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; phosphoprotein binding [GO:0051219]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; ubiquitin protein ligase binding [GO:0031625]; apoptotic process [GO:0006915]; cell cycle arrest [GO:0007050]; cell death [GO:0008219]; cellular protein localization [GO:0034613]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; modulation by virus of host morphology or physiology [GO:0019048]; negative regulation of autophagy [GO:0010507]; positive regulation of cytolysis [GO:0045919]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; protein ubiquitination [GO:0016567]; regulation of macroautophagy [GO:0016241],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:8995684, ECO:0000269|PubMed:9394008}. Nucleus {ECO:0000269|PubMed:8995684, ECO:0000269|PubMed:9394008}. Lysosome {ECO:0000269|PubMed:20381137}. Note=Predominantly cytoplasmic. May shuttle between the cytoplasm and nucleus, depending on the bound nucleotide state (PubMed:8995684, PubMed:9394008). Colocalizes in vivo with adenovirus E3-14.7K mainly to the cytoplasm especially near the nuclear membrane and in discrete foci on or near the plasma membrane (PubMed:8995684). {ECO:0000269|PubMed:20381137, ECO:0000269|PubMed:8995684, ECO:0000269|PubMed:9394008}.",Ras-related GTP-binding protein A (Rag A) (RagA) (Adenovirus E3 14.7 kDa-interacting protein 1) (FIP-1),GO:0003924; GO:0005525; GO:0005634; GO:0005737; GO:0005764; GO:0005765; GO:0005829; GO:0006915; GO:0007050; GO:0008219; GO:0010507; GO:0016241; GO:0016567; GO:0019048; GO:0031625; GO:0032008; GO:0034198; GO:0034448; GO:0034613; GO:0042803; GO:0045919; GO:0046982; GO:0051219; GO:0071230; GO:1904263; GO:1990131,1.00E-07,1.00E-07,1.00E-07,0.029134344,0.047219122,0.034649785,0.034649785,-4.851009807,0.037000984,0.018500592,7.18424699,0.00147648,0.024056784,-4.012945446,36566,1.618762436,3,3,0,1.00E-07,0.034649785,346497.8458,18.40248686,-5.101135362,-4.404484966,-4.851009807,1
Q9NUM4,TMEM106B,T106B_HUMAN,endosome [GO:0005768]; integral component of membrane [GO:0016021]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; dendrite morphogenesis [GO:0048813]; lysosomal transport [GO:0007041]; lysosome localization [GO:0032418]; lysosome organization [GO:0007040]; positive regulation of dendrite development [GO:1900006],SUBCELLULAR LOCATION: Late endosome membrane; Single-pass type II membrane protein. Lysosome membrane; Single-pass type II membrane protein. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}.,Transmembrane protein 106B,GO:0005764; GO:0005765; GO:0005768; GO:0007040; GO:0007041; GO:0016021; GO:0031902; GO:0032418; GO:0048813; GO:1900006,0.026116665,0.049471929,0.05189482,0.293183163,0.239182853,0.196478817,0.239182853,-2.063814127,0.200453806,0.142721374,7.142611953,0.001511523,0.024229658,-4.041458416,31127,1.615652709,4,0,0,0.049471929,0.239182853,4.834718512,2.273431895,-1.770125839,-2.063814127,-2.347554319,1
Q08629,SPOCK1,TICN1_HUMAN,cytoplasm [GO:0005737]; extracellular space [GO:0005615]; neuromuscular junction [GO:0031594]; node of Ranvier [GO:0033268]; postsynaptic density [GO:0014069]; sarcoplasm [GO:0016528]; calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity [GO:0004869]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]; central nervous system neuron differentiation [GO:0021953]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; neurogenesis [GO:0022008]; neuron migration [GO:0001764]; regulation of cell growth [GO:0001558]; signal transduction [GO:0007165],"SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix.",Testican-1 (Protein SPOCK),GO:0001558; GO:0001764; GO:0004867; GO:0004869; GO:0005509; GO:0005615; GO:0005737; GO:0007155; GO:0007165; GO:0007399; GO:0008191; GO:0010812; GO:0010951; GO:0010977; GO:0014069; GO:0016528; GO:0021953; GO:0022008; GO:0031594; GO:0033268,0.000111628,8.35E-05,0.023292992,0.191897939,0.306586415,0.230312767,0.230312767,-2.118333711,0.235103004,0.125380872,7.064796295,0.001579769,0.024858133,-4.09512698,49124,1.604531492,6,0,0,0.000111628,0.230312767,2063.214312,11.01067797,-2.381588875,-1.705634325,-2.118333711,1
Q9Y6X3,MAU2,SCC4_HUMAN,chromatin [GO:0000785]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Scc2-Scc4 cohesin loading complex [GO:0090694]; SMC loading complex [GO:0032116]; double-stranded DNA binding [GO:0003690]; protein N-terminus binding [GO:0047485]; cell division [GO:0051301]; cohesin loading [GO:0071921]; maintenance of mitotic sister chromatid cohesion [GO:0034088],"SUBCELLULAR LOCATION: Nucleus, nucleoplasm {ECO:0000269|PubMed:16682347, ECO:0000269|PubMed:16802858}. Nucleus {ECO:0000269|PubMed:28167679}. Chromosome {ECO:0000250|UniProtKB:Q9D2X5}. Note=Binds to chromatin from the end of mitosis until prophase.",MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog),GO:0000785; GO:0003690; GO:0005634; GO:0005654; GO:0016604; GO:0032116; GO:0034088; GO:0047485; GO:0051301; GO:0071921; GO:0090694,2.01E-05,1.69E-05,1.87E-06,0.023605157,0.040156869,0.035150129,0.035150129,-4.830326213,0.032957766,0.016491835,6.987510413,0.001651293,0.025377137,-4.148924405,69082,1.595557383,7,0,0,1.69E-05,0.035150129,2084.507832,11.02549108,-5.404754102,-4.6382094,-4.830326213,1
Q9NRF2,SH2B1,SH2B1_HUMAN,cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; signaling adaptor activity [GO:0035591]; blood coagulation [GO:0007596]; lamellipodium assembly [GO:0030032]; positive regulation of mitotic nuclear division [GO:0045840]; regulation of DNA biosynthetic process [GO:2000278]; signal transduction [GO:0007165],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Membrane {ECO:0000305}. Nucleus {ECO:0000250}. Note=Shuttles between the nucleus and the cytoplasm. {ECO:0000250}.,"SH2B adapter protein 1 (Pro-rich, PH and SH2 domain-containing signaling mediator) (PSM) (SH2 domain-containing protein 1B)",GO:0005634; GO:0005829; GO:0007165; GO:0007596; GO:0016020; GO:0030032; GO:0035591; GO:0045840; GO:2000278,0.000601641,0.003299465,0.000360501,0.073347115,0.065039067,0.043752207,0.065039067,-3.942549636,0.059292261,0.031066666,6.951186446,0.001686265,0.025638417,-4.174381377,79366,1.591108789,6,0,0,0.000601641,0.065039067,108.1028249,6.756260414,-3.76911597,-3.942549636,-4.514500412,1
Q9UI10,EIF2B4,EI2BD_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic translation initiation factor 2B complex [GO:0005851]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]; myelination [GO:0042552]; oligodendrocyte development [GO:0014003]; ovarian follicle development [GO:0001541]; regulation of translation [GO:0006417]; response to glucose [GO:0009749]; response to heat [GO:0009408]; response to peptide hormone [GO:0043434]; T cell receptor signaling pathway [GO:0050852]; translational initiation [GO:0006413],,Translation initiation factor eIF-2B subunit delta (eIF-2B GDP-GTP exchange factor subunit delta),GO:0001541; GO:0003743; GO:0005737; GO:0005829; GO:0005851; GO:0006413; GO:0006417; GO:0009408; GO:0009749; GO:0014003; GO:0031369; GO:0042552; GO:0043434; GO:0050852,1.00E-07,1.92E-05,1.00E-07,0.053565544,0.056550819,0.033211643,0.053565544,-4.222550914,0.04776953,0.023891237,6.768818711,0.001876078,0.027369195,-4.303892435,57557,1.562737978,16,2,0,1.00E-07,0.053565544,535655.4359,19.03094575,-4.222550914,-4.144308272,-4.912167088,1
Q96F63,CCDC97,CCD97_HUMAN,U2 snRNP [GO:0005686],,Coiled-coil domain-containing protein 97,GO:0005686,1.00E-07,1.00E-07,1.00E-07,0.085005059,0.094250232,0.053994103,0.085005059,-3.556307487,0.077749698,0.038874949,6.636164256,0.002030599,0.028778022,-4.399927499,38947,1.54093906,3,3,0,1.00E-07,0.085005059,850050.589,19.69718918,-3.556307487,-3.407360026,-4.211054336,1
P48664,SLC1A6,EAA4_HUMAN,Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; intermediate filament cytoskeleton [GO:0045111]; membrane [GO:0016020]; plasma membrane [GO:0005886]; amino acid transmembrane transporter activity [GO:0015171]; high-affinity glutamate transmembrane transporter activity [GO:0005314]; L-aspartate transmembrane transporter activity [GO:0015183]; metal ion binding [GO:0046872]; aspartate transmembrane transport [GO:0015810]; chemical synaptic transmission [GO:0007268]; glutamate secretion [GO:0014047]; ion transport [GO:0006811]; L-glutamate import across plasma membrane [GO:0098712]; L-glutamate transmembrane transport [GO:0015813]; regulation of membrane potential [GO:0042391],SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7791878}; Multi-pass membrane protein {ECO:0000305}.,Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6),GO:0005314; GO:0005794; GO:0005886; GO:0005887; GO:0006811; GO:0007268; GO:0014047; GO:0015171; GO:0015183; GO:0015810; GO:0015813; GO:0016020; GO:0042391; GO:0045111; GO:0046872; GO:0098712,1.00E-07,0.000834455,1.00E-07,0.263192055,0.163745725,0.175143387,0.175143387,-2.513391577,0.200415504,0.10048597,6.627306205,0.002041457,0.028788914,-4.406396405,61565,1.540774721,4,2,0,1.00E-07,0.175143387,1751433.871,20.74010509,-1.925812156,-2.610470851,-2.513391577,1
O95639,CPSF4,CPSF4_HUMAN,"intracellular membrane-bounded organelle [GO:0043231]; mRNA cleavage and polyadenylation specificity factor complex [GO:0005847]; nucleoplasm [GO:0005654]; endoribonuclease activity [GO:0004521]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270]; modification by virus of host mRNA processing [GO:0046778]; mRNA 3'-end processing [GO:0031124]; mRNA export from nucleus [GO:0006406]; mRNA polyadenylation [GO:0006378]; mRNA splicing, via spliceosome [GO:0000398]; pre-mRNA cleavage required for polyadenylation [GO:0098789]; termination of RNA polymerase II transcription [GO:0006369]",SUBCELLULAR LOCATION: Nucleus.,Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit) (CPSF 30 kDa subunit) (NS1 effector domain-binding protein 1) (Neb-1) (No arches homolog),GO:0000398; GO:0003723; GO:0004521; GO:0005654; GO:0005847; GO:0006369; GO:0006378; GO:0006406; GO:0008270; GO:0031124; GO:0043231; GO:0046778; GO:0098789,0.024643047,0.031044754,0.027813861,0.098618149,0.083241376,0.06840327,0.083241376,-3.586555372,0.055587045,0.05562741,6.477884364,0.002235684,0.030328777,-4.516598322,30255,1.518145106,7,0,0,0.027813861,0.083241376,2.992801925,1.581496799,-3.342003008,-3.586555372,-3.869790888,1
P21281,ATP6V1B2,VATB2_HUMAN,"cytosol [GO:0005829]; endomembrane system [GO:0012505]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; microvillus [GO:0005902]; myelin sheath [GO:0043209]; plasma membrane [GO:0005886]; proton-transporting V-type ATPase, V1 domain [GO:0033180]; ruffle [GO:0001726]; ATP binding [GO:0005524]; proton transmembrane transporter activity [GO:0015078]; proton-transporting ATPase activity, rotational mechanism [GO:0046961]; ATP hydrolysis coupled proton transport [GO:0015991]; ATP metabolic process [GO:0046034]; insulin receptor signaling pathway [GO:0008286]; ion transmembrane transport [GO:0034220]; proton transmembrane transport [GO:1902600]; regulation of macroautophagy [GO:0016241]; transferrin transport [GO:0033572]",SUBCELLULAR LOCATION: Endomembrane system; Peripheral membrane protein. Melanosome. Note=Endomembrane. Identified by mass spectrometry in melanosome fractions from stage I to stage IV.,"V-type proton ATPase subunit B, brain isoform (V-ATPase subunit B 2) (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2)",GO:0001726; GO:0005524; GO:0005765; GO:0005829; GO:0005886; GO:0005902; GO:0008286; GO:0012505; GO:0015078; GO:0015991; GO:0016021; GO:0016241; GO:0033180; GO:0033572; GO:0034220; GO:0042470; GO:0043209; GO:0043231; GO:0046034; GO:0046961; GO:0070062; GO:1902600,1.00E-07,1.00E-07,1.00E-07,0.031135052,0.025105993,0.017438623,0.025105993,-5.315824389,0.024559789,0.012279995,6.438545629,0.002290498,0.03097419,-4.545955862,56501,1.50900004,12,3,0,1.00E-07,0.025105993,251059.9323,17.93767228,-5.005316502,-5.315824389,-5.841570069,1
A4D1P6,WDR91,WDR91_HUMAN,cytosol [GO:0005829]; early endosome membrane [GO:0031901]; extrinsic component of endosome membrane [GO:0031313]; late endosome membrane [GO:0031902]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; early endosome to late endosome transport [GO:0045022]; regulation of cellular protein catabolic process [GO:1903362]; regulation of phosphatidylinositol 3-kinase activity [GO:0043551],"SUBCELLULAR LOCATION: Early endosome membrane {ECO:0000269|PubMed:26783301}; Peripheral membrane protein {ECO:0000269|PubMed:26783301}. Late endosome membrane {ECO:0000269|PubMed:26783301, ECO:0000269|PubMed:28404643}.",WD repeat-containing protein 91,GO:0005829; GO:0031313; GO:0031901; GO:0031902; GO:0035014; GO:0043551; GO:0045022; GO:1903362,0.005294582,0.014430289,0.009011716,0.030747398,0.040647118,0.032475767,0.032475767,-4.944492579,0.025044565,0.022101145,6.434195276,0.002296659,0.030985924,-4.549211362,83344,1.508835555,15,0,0,0.009011716,0.032475767,3.603727203,1.849489805,-5.023391866,-4.620703137,-4.944492579,1
O43865,AHCYL1,SAHH2_HUMAN,apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; angiotensin-activated signaling pathway [GO:0038166]; epithelial fluid transport [GO:0042045]; mRNA polyadenylation [GO:0006378]; one-carbon metabolic process [GO:0006730]; positive regulation of sodium ion transport [GO:0010765]; protein export from nucleus [GO:0006611]; regulation of anion transport [GO:0044070]; regulation of cardiac conduction [GO:1903779]; regulation of ion transmembrane transporter activity [GO:0032412]; regulation of mRNA 3'-end processing [GO:0031440]; response to calcium ion [GO:0051592]; S-adenosylmethionine cycle [GO:0033353],"SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000250|UniProtKB:Q80SW1}. Cytoplasm, cytosol {ECO:0000250|UniProtKB:Q80SW1}. Microsome {ECO:0000250|UniProtKB:Q80SW1}. Apical cell membrane {ECO:0000250|UniProtKB:B5DFN2}. Note=Associates with membranes when phosphorylated, probably through interaction with ITPR1. {ECO:0000250|UniProtKB:Q80SW1}.",S-adenosylhomocysteine hydrolase-like protein 1 (DC-expressed AHCY-like molecule) (IP(3)Rs binding protein released with IP(3)) (IRBIT) (Putative adenosylhomocysteinase 2) (S-adenosyl-L-homocysteine hydrolase 2) (AdoHcyase 2),GO:0003723; GO:0005737; GO:0005789; GO:0005829; GO:0006378; GO:0006611; GO:0006730; GO:0010765; GO:0016324; GO:0031440; GO:0032412; GO:0033353; GO:0038166; GO:0042045; GO:0042802; GO:0044070; GO:0051592; GO:0070062; GO:1903779,0.005524534,4.93E-05,7.24E-05,0.03773068,0.033330796,0.02271165,0.033330796,-4.907000416,0.029375625,0.016569896,6.33831178,0.002437696,0.032351442,-4.621420316,58951,1.49010635,7,0,0,7.24E-05,0.033330796,460.2325831,8.846219315,-4.728118082,-4.907000416,-5.460423654,1
O43924,PDE6D,PDE6D_HUMAN,"cilium [GO:0005929]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; GTPase inhibitor activity [GO:0005095]; Rab GTPase binding [GO:0017137]; response to stimulus [GO:0050896]; visual perception [GO:0007601]","SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:22002721, ECO:0000269|PubMed:23698361, ECO:0000269|PubMed:9712853}. Cytoplasmic vesicle membrane {ECO:0000269|PubMed:9712853}; Peripheral membrane protein {ECO:0000269|PubMed:9712853}. Cytoplasm, cytoskeleton, cilium basal body {ECO:0000269|PubMed:24166846}.","Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (GMP-PDE delta) (Protein p17)",GO:0004114; GO:0005095; GO:0005829; GO:0005856; GO:0005929; GO:0007601; GO:0017137; GO:0030659; GO:0031410; GO:0050896,1.88E-06,1.00E-07,0.002180566,0.122409044,0.123106735,0.070689311,0.122409044,-3.030217944,0.104674181,0.053064606,6.260794054,0.002559446,0.03339765,-4.680444837,17420,1.476284088,3,1,0,1.88E-06,0.122409044,65107.96195,15.99054636,-3.030217944,-3.0220184,-3.822364108,1
Q9H0S4,DDX47,DDX47_HUMAN,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; mRNA processing [GO:0006397]; RNA secondary structure unwinding [GO:0010501]; RNA splicing [GO:0008380]; rRNA processing [GO:0006364],"SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:12429849, ECO:0000269|PubMed:16963496}. Note=Localizes in the nucleolar-organizing region during ribosome biogenesis.",Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47),GO:0003723; GO:0004004; GO:0005524; GO:0005654; GO:0005730; GO:0005737; GO:0006364; GO:0006397; GO:0008380; GO:0008625; GO:0010501; GO:0016020,2.72E-05,1.00E-07,1.00E-07,0.044664726,0.030373837,0.026127144,0.030373837,-5.041027033,0.033712754,0.016865525,6.247299105,0.002581387,0.033581573,-4.690780218,50647,1.473898967,7,2,0,1.00E-07,0.030373837,303738.3673,18.21246963,-4.484720265,-5.041027033,-5.258306776,1
Q9BQA1,WDR77,MEP50_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; methylosome [GO:0034709]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ligand-dependent nuclear receptor transcription coactivator activity [GO:0030374]; methyl-CpG binding [GO:0008327]; protein-arginine N-methyltransferase activity [GO:0016274]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; positive regulation of cell proliferation [GO:0008284]; regulation of transcription by RNA polymerase II [GO:0006357]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17437848, ECO:0000269|PubMed:21081503}. Cytoplasm {ECO:0000269|PubMed:17437848, ECO:0000269|PubMed:21081503}. Note=Nuclear in Leydig cells and cytoplasmic in germ cells during fetal testicular development. In adult testis, predominantly nuclear. Subcellular location varies from nuclear to cytoplasmic in various tumors (PubMed:17437848). {ECO:0000269|PubMed:17437848}.",Methylosome protein 50 (MEP-50) (Androgen receptor cofactor p44) (WD repeat-containing protein 77) (p44/Mep50),GO:0005634; GO:0005654; GO:0005737; GO:0005794; GO:0005829; GO:0006357; GO:0008284; GO:0008327; GO:0016274; GO:0030374; GO:0034709; GO:0060528; GO:0060770,1.00E-07,0.000983542,1.00E-07,0.022759769,0.037209012,0.024093623,0.024093623,-5.375204867,0.027692887,0.014174358,6.225531618,0.002617261,0.033893723,-4.707489024,36724,1.46988073,6,2,0,1.00E-07,0.024093623,240936.2254,17.8782918,-5.457370276,-4.748204105,-5.375204867,1
Q15742,NAB2,NAB2_HUMAN,"nucleus [GO:0005634]; identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714]; transcription factor binding [GO:0008134]; cell proliferation [GO:0008283]; endochondral ossification [GO:0001958]; myelination [GO:0042552]; negative regulation of transcription by RNA polymerase III [GO:0016480]; nervous system development [GO:0007399]; positive regulation of tau-protein kinase activity [GO:1902949]; regulation of epidermis development [GO:0045682]; Schwann cell differentiation [GO:0014037]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Isoform 2 is not localized to the nucleus. {ECO:0000250}.,NGFI-A-binding protein 2 (EGR-1-binding protein 2) (Melanoma-associated delayed early response protein) (Protein MADER),GO:0001958; GO:0003714; GO:0005634; GO:0006351; GO:0007399; GO:0008134; GO:0008283; GO:0014037; GO:0016480; GO:0042552; GO:0042802; GO:0045682; GO:1902949,0.043802334,0.041485395,0.056178354,0.195399541,0.268301431,0.178527853,0.195399541,-2.355501017,0.166920914,0.130615818,6.211921605,0.002639997,0.034033696,-4.717959874,56594,1.468090881,3,0,0,0.043802334,0.195399541,4.460938985,2.157347416,-2.355501017,-1.898073345,-2.485778922,1
Q8NI60,COQ8A,COQ8A_HUMAN,integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; phosphorylation [GO:0016310]; ubiquinone biosynthetic process [GO:0006744],"SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:11888884, ECO:0000269|PubMed:25498144}. Membrane {ECO:0000255}; Single-pass membrane protein {ECO:0000255, ECO:0000305|PubMed:25216398}.","Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)",GO:0005524; GO:0005739; GO:0006744; GO:0016021; GO:0016301; GO:0016310; GO:0043531,1.00E-07,1.00E-07,1.00E-07,0.109156103,0.06490531,0.070502883,0.070502883,-3.826173936,0.081521332,0.040760766,6.08905255,0.002856467,0.035539763,-4.813325826,71950,1.449285478,8,3,0,1.00E-07,0.070502883,705028.83,19.42732273,-3.195535304,-3.945519688,-3.826173936,1
P15289,ARSA,ARSA_HUMAN,azurophil granule lumen [GO:0035578]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; lysosomal lumen [GO:0043202]; lysosome [GO:0005764]; arylsulfatase activity [GO:0004065]; calcium ion binding [GO:0005509]; cerebroside-sulfatase activity [GO:0004098]; sulfuric ester hydrolase activity [GO:0008484]; glycosphingolipid metabolic process [GO:0006687]; neutrophil degranulation [GO:0043312],SUBCELLULAR LOCATION: Endoplasmic reticulum {ECO:0000269|PubMed:9342345}. Lysosome {ECO:0000305|PubMed:2562955}.,Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase) [Cleaved into: Arylsulfatase A component B; Arylsulfatase A component C],GO:0004065; GO:0004098; GO:0005509; GO:0005576; GO:0005764; GO:0005788; GO:0006687; GO:0008484; GO:0035578; GO:0043202; GO:0043312; GO:0070062,1.00E-07,1.00E-07,1.00E-07,0.006906616,0.00982997,0.005511384,0.006906616,-7.177805192,0.00741589,0.003708045,6.050262125,0.002929228,0.035974445,-4.843750272,53588,1.444005892,8,3,0,1.00E-07,0.006906616,69066.16379,16.07569147,-7.177805192,-6.668597273,-7.503369548,1
Q9UBU9,NXF1,NXF1_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear pore [GO:0005643]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; mRNA export from nucleus [GO:0006406]; poly(A)+ mRNA export from nucleus [GO:0016973]; RNA export from nucleus [GO:0006405]; viral process [GO:0016032],"SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10924507, ECO:0000269|PubMed:19864460, ECO:0000269|PubMed:25662211}. Nucleus, nucleoplasm {ECO:0000269|PubMed:19324961, ECO:0000269|PubMed:23826332}. Nucleus speckle {ECO:0000269|PubMed:19324961, ECO:0000269|PubMed:23826332}. Cytoplasm {ECO:0000269|PubMed:10924507, ECO:0000269|PubMed:19324961, ECO:0000269|PubMed:19864460}. Note=Localized predominantly in the nucleoplasm and at both the nucleoplasmic and cytoplasmic faces of the nuclear pore complex. Shuttles between the nucleus and the cytoplasm. Travels to the cytoplasm as part of the exon junction complex (EJC) bound to mRNA. The association with the TREX complex seems to occur in regions surrounding nuclear speckles known as perispeckles (PubMed:23826332). Nucleus; nuclear rim (PubMed:25662211). {ECO:0000269|PubMed:23826332, ECO:0000269|PubMed:25662211}.",Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP),GO:0003723; GO:0003729; GO:0005634; GO:0005643; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006406; GO:0016032; GO:0016607; GO:0016973; GO:0042405,0.000118805,6.27E-05,0.001227952,0.075441516,0.081573672,0.044420084,0.075441516,-3.728497525,0.066675273,0.033807454,6.021404286,0.002984815,0.036396033,-4.866484323,70182,1.438945951,9,0,0,0.000118805,0.075441516,635.0020465,9.310617431,-3.728497525,-3.615752595,-4.492644056,1
Q9NS39,ADARB2,RED2_HUMAN,nucleus [GO:0005634]; adenosine deaminase activity [GO:0004000]; double-stranded RNA binding [GO:0003725]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; single-stranded RNA binding [GO:0003727]; mRNA processing [GO:0006397],SUBCELLULAR LOCATION: Nucleus.,Double-stranded RNA-specific editase B2 (EC 3.5.-.-) (RNA-dependent adenosine deaminase 3) (RNA-editing deaminase 2) (RNA-editing enzyme 2) (dsRNA adenosine deaminase B2),GO:0003723; GO:0003725; GO:0003727; GO:0004000; GO:0005634; GO:0006397; GO:0046872,0.000128628,0.000116948,0.029203602,0.685546112,0.635157165,0.368022712,0.635157165,-0.654814474,0.55309227,0.286362528,5.805306547,0.003444251,0.039734212,-5.03949327,80621,1.400835392,5,0,0,0.000128628,0.635157165,4937.931159,12.26969101,-0.544674385,-0.654814474,-1.442133294,1
Q9GZR7,DDX24,DDX24_HUMAN,cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleolus [GO:0005730]; ATP binding [GO:0005524]; ATP-dependent RNA helicase activity [GO:0004004]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA metabolic process [GO:0016070]; RNA secondary structure unwinding [GO:0010501],,ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24),GO:0003723; GO:0003724; GO:0004004; GO:0005524; GO:0005730; GO:0005737; GO:0010501; GO:0016020; GO:0016070,0.000142388,0.010744629,0.000174439,0.023064858,0.023016445,0.025945916,0.023064858,-5.438159771,0.020321921,0.013848112,5.770031867,0.003527138,0.040238183,-5.068207539,96332,1.395361641,11,0,0,0.000174439,0.023064858,132.2232198,7.046831742,-5.438159771,-5.441191191,-5.268348733,1
Q9BZR6,RTN4R,RTN4R_HUMAN,anchored component of external side of plasma membrane [GO:0031362]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; dendritic shaft [GO:0043198]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; chondroitin sulfate binding [GO:0035374]; ganglioside GM1 binding [GO:1905573]; ganglioside GT1b binding [GO:1905576]; heparin binding [GO:0008201]; neuregulin receptor activity [GO:0038131]; protein kinase inhibitor activity [GO:0004860]; signaling receptor activity [GO:0038023]; axonogenesis [GO:0007409]; cell surface receptor signaling pathway [GO:0007166]; corpus callosum development [GO:0022038]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of axon extension [GO:0030517]; negative regulation of axon regeneration [GO:0048681]; negative regulation of axonogenesis [GO:0050771]; negative regulation of JAK-STAT cascade [GO:0046426]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein kinase activity [GO:0006469]; neuronal signal transduction [GO:0023041]; positive regulation of GTPase activity [GO:0043547]; positive regulation of Rho protein signal transduction [GO:0035025],"SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12426574, ECO:0000269|PubMed:12694398, ECO:0000269|PubMed:12839991, ECO:0000269|PubMed:16712417, ECO:0000269|PubMed:18411262}; Lipid-anchor, GPI-anchor {ECO:0000269|PubMed:12694398}. Membrane raft {ECO:0000269|PubMed:12694398}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q99PI8}. Cell projection, axon {ECO:0000250|UniProtKB:Q99PI8}. Perikaryon {ECO:0000250|UniProtKB:Q99M75}. Note=Detected along dendrites and axons, close to synapses, but clearly excluded from synapses. {ECO:0000250|UniProtKB:Q99PI8}.",Reticulon-4 receptor (Nogo receptor) (NgR) (Nogo-66 receptor),GO:0004860; GO:0005737; GO:0005783; GO:0005886; GO:0005887; GO:0006469; GO:0007166; GO:0007409; GO:0008201; GO:0009986; GO:0010977; GO:0019221; GO:0022038; GO:0023041; GO:0030517; GO:0031362; GO:0035025; GO:0035374; GO:0038023; GO:0038131; GO:0043005; GO:0043025; GO:0043198; GO:0043204; GO:0043547; GO:0044295; GO:0045121; GO:0046426; GO:0048681; GO:0050771; GO:0070062; GO:1905573; GO:1905576,0.413150975,0.479561421,0.497816721,0.726203527,0.666122023,0.630519366,0.666122023,-0.586141615,0.210771933,0.568895672,5.768730323,0.003530242,0.040238183,-5.069269607,50708,1.395361641,4,0,0,0.479561421,0.666122023,1.389023373,0.474070876,-0.461554158,-0.586141615,-0.665387411,1
Q96RT7,TUBGCP6,GCP6_HUMAN,centrosome [GO:0005813]; cytosol [GO:0005829]; equatorial microtubule organizing center [GO:0000923]; gamma-tubulin ring complex [GO:0008274]; membrane [GO:0016020]; microtubule [GO:0005874]; spindle pole [GO:0000922]; gamma-tubulin binding [GO:0043015]; microtubule binding [GO:0008017]; structural constituent of cytoskeleton [GO:0005200]; centrosome duplication [GO:0051298]; cytoplasmic microtubule organization [GO:0031122]; meiotic cell cycle [GO:0051321]; microtubule nucleation [GO:0007020]; microtubule nucleation by interphase microtubule organizing center [GO:0051415]; mitotic spindle assembly [GO:0090307],"SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:11694571}.",Gamma-tubulin complex component 6 (GCP-6),GO:0000922; GO:0000923; GO:0005200; GO:0005813; GO:0005829; GO:0005874; GO:0007020; GO:0008017; GO:0008274; GO:0016020; GO:0031122; GO:0043015; GO:0051298; GO:0051321; GO:0051415; GO:0090307,0.000603179,1.00E-07,1.00E-07,0.156513934,0.220453457,0.117860453,0.156513934,-2.675636989,0.164741489,0.082571871,5.722266631,0.003643249,0.040980569,-5.107305611,200498,1.387422015,3,2,0,1.00E-07,0.156513934,1565139.345,20.57785968,-2.675636989,-2.181453994,-3.084848381,1
Q643R3,LPCAT4,LPCT4_HUMAN,endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; 1-acylglycerol-3-phosphate O-acyltransferase activity [GO:0003841]; 1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; 1-alkenylglycerophosphoethanolamine O-acyltransferase activity [GO:0047166]; 1-alkylglycerophosphocholine O-acetyltransferase activity [GO:0047192]; 2-acylglycerol-3-phosphate O-acyltransferase activity [GO:0047144]; lysophospholipid acyltransferase activity [GO:0071617]; phosphatidic acid biosynthetic process [GO:0006654]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; phosphatidylethanolamine acyl-chain remodeling [GO:0036152]; phosphatidylglycerol acyl-chain remodeling [GO:0036148]; phosphatidylserine acyl-chain remodeling [GO:0036150]; phospholipid metabolic process [GO:0006644],"SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:16243729, ECO:0000269|PubMed:18458083}; Multi-pass membrane protein {ECO:0000269|PubMed:16243729, ECO:0000269|PubMed:18458083}.",Lysophospholipid acyltransferase LPCAT4 (1-acylglycerol-3-phosphate O-acyltransferase 7) (1-AGP acyltransferase 7) (1-AGPAT 7) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (1-alkenylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.121) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 3) (Lysophosphatidylcholine acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase 2) (EC 2.3.1.n7) (Plasmalogen synthase),GO:0003841; GO:0005783; GO:0005789; GO:0006644; GO:0006654; GO:0016020; GO:0016021; GO:0036148; GO:0036150; GO:0036151; GO:0036152; GO:0047144; GO:0047166; GO:0047184; GO:0047192; GO:0071617,7.33E-05,1.00E-07,1.00E-07,0.149648315,0.155850987,0.081790022,0.149648315,-2.740352056,0.129071947,0.064560468,5.653995082,0.003817326,0.042054456,-5.163625681,57219,1.376187982,8,2,0,1.00E-07,0.149648315,1496483.155,20.51314461,-2.740352056,-2.681760807,-3.611931331,1
Q147X3,NAA30,NAA30_HUMAN,cytoplasm [GO:0005737]; cytosol [GO:0005829]; NatC complex [GO:0031417]; nucleus [GO:0005634]; peptide alpha-N-acetyltransferase activity [GO:0004596]; N-terminal peptidyl-methionine acetylation [GO:0017196],"SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19398576, ECO:0000269|PubMed:25732826}. Nucleus {ECO:0000269|PubMed:25732826}.",N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit),GO:0004596; GO:0005634; GO:0005737; GO:0005829; GO:0017196; GO:0031417,1.00E-07,1.00E-07,0.00190523,0.038281071,0.044842982,0.069357792,0.044842982,-4.478973974,0.050192139,0.025731213,5.502471371,0.004240892,0.044651949,-5.290495023,39320,1.350159576,7,2,0,1.00E-07,0.044842982,448429.8192,18.77452269,-4.707224982,-4.478973974,-3.849798209,1
P54098,POLG,DPOG1_HUMAN,"gamma DNA polymerase complex [GO:0005760]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; protein-containing complex [GO:0032991]; terminal bouton [GO:0043195]; 3'-5' exonuclease activity [GO:0008408]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; protease binding [GO:0002020]; aging [GO:0007568]; base-excision repair, gap-filling [GO:0006287]; cellular response to glucose stimulus [GO:0071333]; DNA metabolic process [GO:0006259]; DNA-dependent DNA replication [GO:0006261]; mitochondrial DNA replication [GO:0006264]; response to gamma radiation [GO:0010332]; response to hyperoxia [GO:0055093]; response to light stimulus [GO:0009416]","SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:18063578}. Mitochondrion matrix, mitochondrion nucleoid {ECO:0000269|PubMed:18063578}.",DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha),GO:0002020; GO:0003677; GO:0003682; GO:0003887; GO:0005739; GO:0005760; GO:0006259; GO:0006261; GO:0006264; GO:0006287; GO:0007568; GO:0008408; GO:0009416; GO:0010332; GO:0032991; GO:0042645; GO:0043195; GO:0055093; GO:0071333,0.000163911,6.73E-05,7.19E-05,0.016848734,0.033707639,0.028444016,0.028444016,-5.135731026,0.026232434,0.013217246,5.473222081,0.004329058,0.045110621,-5.315287534,139562,1.345721197,14,0,0,7.19E-05,0.028444016,395.6596481,8.628116127,-5.89121597,-4.890780594,-5.135731026,1
Q9Y5E9,PCDHB14,PCDBE_HUMAN,integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; calcium ion binding [GO:0005509]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell adhesion [GO:0007155]; chemical synaptic transmission [GO:0007268]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; synapse assembly [GO:0007416],SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.,Protocadherin beta-14 (PCDH-beta-14),GO:0005509; GO:0005887; GO:0007155; GO:0007156; GO:0007268; GO:0007416; GO:0016021; GO:0016339,9.86E-05,0.000135422,0.000156234,0.02362117,0.047313745,0.039902118,0.039902118,-4.647390858,0.03681558,0.018537888,5.466849887,0.004348557,0.045119577,-5.320701937,87548,1.345634983,6,0,0,0.000135422,0.039902118,294.6502327,8.202859595,-5.403775755,-4.401596825,-4.647390858,1
Q8TCT7,SPPL2B,SPP2B_HUMAN,"actin cytoskeleton [GO:0015629]; centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; Golgi-associated vesicle membrane [GO:0030660]; integral component of cytoplasmic side of endoplasmic reticulum membrane [GO:0071458]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; protein homodimerization activity [GO:0042803]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; membrane protein proteolysis [GO:0033619]; regulation of immune response [GO:0050776]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]",SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:16829952}; Multi-pass membrane protein {ECO:0000305}. Golgi apparatus membrane {ECO:0000269|PubMed:17965014}; Multi-pass membrane protein {ECO:0000305}. Lysosome membrane {ECO:0000269|PubMed:15998642}; Multi-pass membrane protein {ECO:0000305}. Endosome membrane {ECO:0000269|PubMed:15998642}; Multi-pass membrane protein {ECO:0000305}. Membrane {ECO:0000269|PubMed:15385547}; Multi-pass membrane protein {ECO:0000305}; Lumenal side {ECO:0000269|PubMed:15385547}. Note=targeted through the entire secretory pathway to endosomes/lysosomes (PubMed:15998642). {ECO:0000269|PubMed:15998642}.,Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) (Intramembrane protease 4) (IMP-4) (Presenilin homologous protein 4) (PSH4) (Presenilin-like protein 1),GO:0000139; GO:0005654; GO:0005765; GO:0005813; GO:0005886; GO:0006509; GO:0010008; GO:0010803; GO:0015629; GO:0016020; GO:0030660; GO:0031293; GO:0033619; GO:0042500; GO:0042803; GO:0050776; GO:0071458; GO:0071556,2.46E-05,6.11E-05,0.000269009,0.027454433,0.013717879,0.022902614,0.022902614,-5.448343923,0.021240057,0.01073828,5.461662356,0.00436451,0.04513745,-5.325113224,64644,1.345462979,6,0,0,6.11E-05,0.022902614,374.7990383,8.549973441,-5.186817071,-6.187798732,-5.448343923,1
Q8TBC5,ZSCAN18,ZSC18_HUMAN,"nucleus [GO:0005634]; DNA binding [GO:0003677]; metal ion binding [GO:0046872]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00187}.,Zinc finger and SCAN domain-containing protein 18 (Zinc finger protein 447),GO:0000981; GO:0003677; GO:0005634; GO:0006351; GO:0046872,9.17E-05,4.58E-05,3.74E-05,0.031507157,0.063128539,0.049557112,0.049557112,-4.334764069,0.048005966,0.024061286,5.446343603,0.004412031,0.045393012,-5.338158026,54804,1.343011,3,0,0,4.58E-05,0.049557112,1081.637553,10.07900143,-4.988176618,-3.985563827,-4.334764069,1
Q9UKZ9,PCOLCE2,PCOC2_HUMAN,extracellular region [GO:0005576]; collagen binding [GO:0005518]; heparin binding [GO:0008201]; peptidase activator activity [GO:0016504]; cellular response to leukemia inhibitory factor [GO:1990830],SUBCELLULAR LOCATION: Secreted {ECO:0000305}.,Procollagen C-endopeptidase enhancer 2 (Procollagen COOH-terminal proteinase enhancer 2) (PCPE-2) (Procollagen C-proteinase enhancer 2),GO:0005518; GO:0005576; GO:0008201; GO:0016504; GO:1990830,3.23E-05,1.36E-06,9.50E-06,0.044258784,0.022080109,0.034453266,0.034453266,-4.859215433,0.033583,0.016805887,5.43808055,0.004437923,0.045436301,-5.345205859,45717,1.342597036,5,0,0,9.50E-06,0.034453266,3626.34384,11.82430001,-4.49789237,-5.501108889,-4.859215433,1
Q9BTU6,PI4K2A,P4K2A_HUMAN,cell junction [GO:0030054]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; growing cell tip [GO:0035838]; host cell presynaptic membrane [GO:0044231]; integral component of plasma membrane [GO:0005887]; intrinsic component of membrane [GO:0031224]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; synaptic vesicle membrane [GO:0030672]; trans-Golgi network [GO:0005802]; 1-phosphatidylinositol 4-kinase activity [GO:0004430]; AP-3 adaptor complex binding [GO:0035651]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; basophil degranulation [GO:0002561]; endosome organization [GO:0007032]; Golgi organization [GO:0007030]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol phosphorylation [GO:0046854],"SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane {ECO:0000269|PubMed:16443754, ECO:0000269|PubMed:22535966}; Lipid-anchor {ECO:0000269|PubMed:22535966}. Membrane raft {ECO:0000269|PubMed:11279162}. Cell projection, dendrite {ECO:0000250|UniProtKB:Q2TBE6}. Cell junction, synapse, presynaptic cell membrane {ECO:0000250|UniProtKB:Q2TBE6}. Cell junction, synapse, synaptosome {ECO:0000250|UniProtKB:Q2TBE6}. Mitochondrion {ECO:0000250|UniProtKB:Q2TBE6}. Endosome {ECO:0000269|PubMed:16443754, ECO:0000269|PubMed:23146885}. Cytoplasmic vesicle {ECO:0000269|PubMed:16443754}. Membrane {ECO:0000269|PubMed:24675427}; Lipid-anchor {ECO:0000269|PubMed:24675427}. Cell membrane {ECO:0000269|PubMed:11279162, ECO:0000269|PubMed:16443754}. Note=Localized in neuronal cell body. Transported from neuronal cell body to neuron projections in a BLOC-1- and AP-3-complexes-dependent manner. Enriched in neurite tips and neuron projections in a BLOC-1- and AP-3-complexes-dependent manner (By similarity). Found in subdomains of the plasma membrane termed non-caveolar membrane rafts. {ECO:0000250|UniProtKB:Q2TBE6, ECO:0000250|UniProtKB:Q99M64}.",Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha),GO:0000287; GO:0002561; GO:0004430; GO:0005524; GO:0005739; GO:0005765; GO:0005768; GO:0005802; GO:0005829; GO:0005887; GO:0006661; GO:0007030; GO:0007032; GO:0016020; GO:0030054; GO:0030425; GO:0030672; GO:0031224; GO:0031410; GO:0031901; GO:0032991; GO:0035651; GO:0035838; GO:0042734; GO:0043005; GO:0043025; GO:0043204; GO:0044231; GO:0045121; GO:0046854,0.00044699,2.46E-05,4.74E-05,0.033444824,0.066851486,0.05158203,0.05158203,-4.276987649,0.050453108,0.025399559,5.428971773,0.004466677,0.045436301,-5.352984294,54022,1.342597036,17,0,0,4.74E-05,0.05158203,1087.917584,10.08735355,-4.902073258,-3.902896563,-4.276987649,1
Q9UK99,FBXO3,FBX3_HUMAN,cytosol [GO:0005829]; nucleoplasm [GO:0005654]; ubiquitin-protein transferase activity [GO:0004842]; proteolysis [GO:0006508],SUBCELLULAR LOCATION: Nucleus. Note=Colocalizes with PML at the peripheries of nuclear bodies.,F-box only protein 3,GO:0004842; GO:0005654; GO:0005829; GO:0006508,1.00E-07,1.00E-07,5.73E-06,0.100964997,0.050399141,0.092630055,0.092630055,-3.432375816,0.081329423,0.040666687,5.399161245,0.004562365,0.045727145,-5.378509042,54561,1.339825916,6,2,0,1.00E-07,0.092630055,926300.5523,19.82112085,-3.308072876,-4.310457042,-3.432375816,1
Q96FV2,SCRN2,SCRN2_HUMAN,extracellular exosome [GO:0070062]; dipeptidase activity [GO:0016805]; exocytosis [GO:0006887],,Secernin-2,GO:0006887; GO:0016805; GO:0070062,0.00015797,0.00022779,0.058805627,0.178381303,0.132973843,0.13297599,0.13297599,-2.910762313,0.128379916,0.083920421,5.397621853,0.004567373,0.045727145,-5.379829959,46597,1.339825916,3,0,0,0.00022779,0.13297599,583.7654648,9.189245054,-2.486963688,-2.910785611,-2.910762313,1
Q9BRX2,PELO,PELO_HUMAN,"cytoplasm [GO:0005737]; nucleus [GO:0005634]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; ribosome binding [GO:0043022]; cell cycle [GO:0007049]; cell division [GO:0051301]; cell proliferation [GO:0008283]; chromosome organization [GO:0051276]; endoderm development [GO:0007492]; mesenchymal to epithelial transition [GO:0060231]; nonfunctional rRNA decay [GO:0070651]; nuclear-transcribed mRNA catabolic process, no-go decay [GO:0070966]; nuclear-transcribed mRNA catabolic process, non-stop decay [GO:0070481]; positive regulation of BMP signaling pathway [GO:0030513]; ribosome disassembly [GO:0032790]; RNA surveillance [GO:0071025]; stem cell population maintenance [GO:0019827]; translation [GO:0006412]",SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Cytoplasm {ECO:0000250}.,Protein pelota homolog (EC 3.1.-.-),GO:0004519; GO:0005634; GO:0005737; GO:0006412; GO:0007049; GO:0007492; GO:0008283; GO:0019827; GO:0030513; GO:0032790; GO:0043022; GO:0046872; GO:0051276; GO:0051301; GO:0060231; GO:0070481; GO:0070651; GO:0070966; GO:0071025,0.002829336,0.022341524,0.005627447,0.132292041,0.115635746,0.072865031,0.115635746,-3.112340656,0.096664837,0.058598521,5.366277383,0.004670795,0.046382839,-5.406786847,43359,1.333642672,4,0,0,0.005627447,0.115635746,20.54852647,4.360963037,-2.918201822,-3.112340656,-3.778629575,1
Q9UJ14,GGT7,GGT7_HUMAN,integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; glutathione hydrolase activity [GO:0036374]; hypoglycin A gamma-glutamyl transpeptidase activity [GO:0102953]; leukotriene C4 gamma-glutamyl transferase activity [GO:0103068]; glutathione biosynthetic process [GO:0006750]; glutathione catabolic process [GO:0006751]; leukotriene D4 biosynthetic process [GO:1901750]; negative regulation of response to oxidative stress [GO:1902883],SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type II membrane protein {ECO:0000250}.,Glutathione hydrolase 7 (EC 3.4.19.13) (Gamma-glutamyltransferase 7) (GGT 7) (EC 2.3.2.2) (Gamma-glutamyltransferase-like 3) (Gamma-glutamyltransferase-like 5) (Gamma-glutamyltranspeptidase 7) [Cleaved into: Glutathione hydrolase 7 heavy chain; Glutathione hydrolase 7 light chain],GO:0005886; GO:0006750; GO:0006751; GO:0016021; GO:0036374; GO:0102953; GO:0103068; GO:1901750; GO:1902883,9.65E-05,9.56E-05,0.000125817,0.011076916,0.022179442,0.016430795,0.016430795,-5.927453869,0.016456431,0.008334169,5.333365196,0.004782441,0.046839463,-5.43521756,70467,1.329388088,9,0,0,9.65E-05,0.016430795,170.3126807,7.412042045,-6.496299908,-5.494633106,-5.927453869,1
Q9ULP9,TBC1D24,TBC24_HUMAN,cell junction [GO:0030054]; cytoplasm [GO:0005737]; neuromuscular junction [GO:0031594]; plasma membrane [GO:0005886]; terminal bouton [GO:0043195]; GTPase activator activity [GO:0005096]; neuron projection development [GO:0031175],SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20727515}. Note=Partially expressed at the plasma membrane.,TBC1 domain family member 24,GO:0005096; GO:0005737; GO:0005886; GO:0030054; GO:0031175; GO:0031594; GO:0043195,7.16E-05,8.76E-05,0.00013915,0.010806108,0.005363833,0.00987482,0.00987482,-6.662029821,0.008582134,0.00439052,5.303192786,0.004887625,0.047381731,-5.461395308,62919,1.324389081,17,0,0,8.76E-05,0.00987482,112.697437,6.816310896,-6.532009152,-7.542519976,-6.662029821,1
Q9NPF5,DMAP1,DMAP1_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; NuA4 histone acetyltransferase complex [GO:0035267]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; replication fork [GO:0005657]; RNA polymerase II repressing transcription factor binding [GO:0001103]; RNA polymerase II transcription factor activity, sequence-specific DNA binding [GO:0000981]; transcription corepressor activity [GO:0003714]; chromatin remodeling [GO:0006338]; DNA methylation [GO:0006306]; DNA repair [GO:0006281]; histone H2A acetylation [GO:0043968]; histone H4 acetylation [GO:0043967]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of protein import into nucleus [GO:0042307]; regulation of growth [GO:0040008]; response to ethanol [GO:0045471]; transcription, DNA-templated [GO:0006351]",SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Targeted to replication foci throughout S phase by DNMT1.,DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1),GO:0000122; GO:0000981; GO:0001103; GO:0003714; GO:0005634; GO:0005654; GO:0005657; GO:0005737; GO:0005829; GO:0006281; GO:0006306; GO:0006338; GO:0006351; GO:0035267; GO:0040008; GO:0042307; GO:0043967; GO:0043968; GO:0045471; GO:0045892,0.000269233,0.003529994,0.000297466,0.150152353,0.105090554,0.209129037,0.150152353,-2.735501012,0.153425083,0.078078106,5.28904246,0.004937912,0.047532913,-5.473709892,52993,1.323005573,11,0,0,0.000297466,0.150152353,504.7707322,8.979484452,-2.735501012,-3.2502951,-2.257534707,1
Q9P0J1,PDP1,PDP1_HUMAN,mitochondrial matrix [GO:0005759]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; metal ion binding [GO:0046872]; protein serine/threonine phosphatase activity [GO:0004722]; peptidyl-threonine dephosphorylation [GO:0035970]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510],SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250}.,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial (PDP 1) (EC 3.1.3.43) (Protein phosphatase 2C) (Pyruvate dehydrogenase phosphatase catalytic subunit 1) (PDPC 1)",GO:0004722; GO:0004741; GO:0005759; GO:0010510; GO:0035970; GO:0046872,0.005450877,0.002731731,0.005811877,0.03685385,0.023929087,0.022917084,0.023929087,-5.385090855,0.023235178,0.016282418,5.259012616,0.00504671,0.047865338,-5.499924049,61054,1.31997887,11,0,0,0.005450877,0.023929087,4.389951358,2.134204954,-4.762040847,-5.385090855,-5.447432724,1
P58004,SESN2,SESN2_HUMAN,"cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleotide-activated protein kinase complex [GO:0031588]; nucleus [GO:0005634]; TORC2 complex [GO:0031932]; GDP-dissociation inhibitor activity [GO:0005092]; leucine binding [GO:0070728]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; sulfiredoxin activity [GO:0032542]; cellular oxidant detoxification [GO:0098869]; cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to glucose starvation [GO:0042149]; cellular response to leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; fatty acid beta-oxidation [GO:0006635]; glucose homeostasis [GO:0042593]; glucose import [GO:0046323]; mitochondrial DNA metabolic process [GO:0032042]; negative regulation of cell growth [GO:0030308]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of translation in response to endoplasmic reticulum stress [GO:1902010]; positive regulation of lipophagy [GO:1904504]; positive regulation of macroautophagy [GO:0016239]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress [GO:0036091]; protein kinase B signaling [GO:0043491]; reactive oxygen species metabolic process [GO:0072593]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of gluconeogenesis [GO:0006111]; regulation of protein phosphorylation [GO:0001932]; regulation of response to reactive oxygen species [GO:1901031]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; triglyceride homeostasis [GO:0070328]",SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15105503}.,Sestrin-2 (EC 1.11.1.15) (Hypoxia-induced gene),GO:0001932; GO:0005092; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006111; GO:0006635; GO:0009749; GO:0016239; GO:0016684; GO:0030308; GO:0030330; GO:0031588; GO:0031932; GO:0032042; GO:0032542; GO:0032868; GO:0034198; GO:0034599; GO:0036091; GO:0042149; GO:0042593; GO:0043491; GO:0046323; GO:0070328; GO:0070728; GO:0071230; GO:0071233; GO:0072593; GO:0098869; GO:1900182; GO:1901031; GO:1902010; GO:1904262; GO:1904504; GO:1990253; GO:2000479,1.00E-07,1.00E-07,1.00E-07,0.019958811,0.009909409,0.01420774,0.01420774,-6.137179074,0.014691887,0.007346043,5.243208388,0.005105126,0.048287155,-5.51376407,54494,1.316168379,4,3,0,1.00E-07,0.01420774,142077.4029,17.11631759,-5.646830396,-6.656985206,-6.137179074,1
Q8WVZ9,KBTBD7,KBTB7_HUMAN,Cul3-RING ubiquitin ligase complex [GO:0031463]; cytosol [GO:0005829]; MAPK cascade [GO:0000165]; post-translational protein modification [GO:0043687]; protein ubiquitination [GO:0016567],,Kelch repeat and BTB domain-containing protein 7,GO:0000165; GO:0005829; GO:0016567; GO:0031463; GO:0043687,0.023688219,0.051025068,0.022541067,0.079932728,0.100948125,0.085756936,0.085756936,-3.543602833,0.056461145,0.06064869,5.228510174,0.005160185,0.048585643,-5.526662841,77163,1.313492046,5,0,0,0.023688219,0.085756936,3.620235691,1.856083625,-3.645069866,-3.30831398,-3.543602833,1
Q02127,DHODH,PYRD_HUMAN,cytosol [GO:0005829]; integral component of membrane [GO:0016021]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; dihydroorotate dehydrogenase activity [GO:0004152]; drug binding [GO:0008144]; FMN binding [GO:0010181]; ubiquinone binding [GO:0048039]; 'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; female pregnancy [GO:0007565]; lactation [GO:0007595]; positive regulation of apoptotic process [GO:0043065]; pyrimidine nucleoside biosynthetic process [GO:0046134]; regulation of mitochondrial fission [GO:0090140]; response to caffeine [GO:0031000]; response to L-arginine [GO:1903576]; response to starvation [GO:0042594],SUBCELLULAR LOCATION: Mitochondrion inner membrane {ECO:0000269|PubMed:10727948}; Single-pass membrane protein {ECO:0000269|PubMed:10727948}.,"Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)",GO:0004152; GO:0005654; GO:0005739; GO:0005743; GO:0005829; GO:0006207; GO:0007565; GO:0007595; GO:0008144; GO:0010181; GO:0016021; GO:0031000; GO:0042594; GO:0043025; GO:0043065; GO:0044205; GO:0046134; GO:0048039; GO:0090140; GO:1903576,1.00E-07,1.00E-07,1.00E-07,0.020038334,0.018669201,0.009691239,0.018669201,-5.743195978,0.016132825,0.008066512,5.165203094,0.005405646,0.049438085,-5.582522178,42867,1.305938359,6,3,0,1.00E-07,0.018669201,186692.0135,17.51030069,-5.641093646,-5.743195978,-6.689103215,1
O94966,USP19,UBP19_HUMAN,cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; Hsp90 protein binding [GO:0051879]; Lys48-specific deubiquitinase activity [GO:1990380]; metal ion binding [GO:0046872]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; thiol-dependent ubiquitinyl hydrolase activity [GO:0036459]; ubiquitin protein ligase binding [GO:0031625]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of skeletal muscle tissue development [GO:0048642]; positive regulation of cell cycle process [GO:0090068]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; regulation of cellular response to hypoxia [GO:1900037]; regulation of ERAD pathway [GO:1904292]; regulation of protein stability [GO:0031647]; response to endoplasmic reticulum stress [GO:0034976]; ubiquitin-dependent ERAD pathway [GO:0030433],SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:19465887}; Single-pass membrane protein {ECO:0000269|PubMed:19465887}.,Ubiquitin carboxyl-terminal hydrolase 19 (EC 3.4.19.12) (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19) (Zinc finger MYND domain-containing protein 9),GO:0004843; GO:0005634; GO:0005789; GO:0005829; GO:0016021; GO:0016579; GO:0030433; GO:0031625; GO:0031647; GO:0034976; GO:0036459; GO:0046872; GO:0048642; GO:0050821; GO:0051879; GO:0090068; GO:1900037; GO:1901799; GO:1904292; GO:1990380,4.50E-05,4.02E-05,6.31E-05,0.008262733,0.016602089,0.01145453,0.01145453,-6.447937913,0.01205698,0.006077961,5.155748681,0.005443498,0.049570574,-5.590906746,145651,1.304776052,16,0,0,4.50E-05,0.01145453,254.3199135,7.990500621,-6.919165256,-5.912491416,-6.447937913,1